Benefits of Digital Health

What are the benefits of digital health?

The benefits of digital health are better access to care, earlier detection through data collected between visits, more patient involvement in their own care and less administrative work for clinicians. They appear only when the tool fits a clinical workflow and someone acts on its data. Buyers pay for benefits they can measure.

That last point shapes everything that follows. A benefit a founder believes in is a hypothesis; a benefit a buyer sees in its own data is a contract renewal.

Which benefits matter to which buyer?

Each buyer frames value in its own terms, and a product pitched on the wrong benefit stalls in procurement. Match the benefit to the buyer before writing the pilot proposal.

• Patients: Less travel and waiting, faster answers, and a clearer view of their own condition. They judge the product by whether it saves them time and whether a person responds when they need one.
• Clinicians: Better information at the moment of decision and fewer clicks, calls and faxes. They reject tools that add a login or a queue nobody staffed.
• Health systems and medical groups: Capacity, fewer avoidable admissions and visits under value-based contracts, and staff time returned. They want results in their own operational reports.
• Health plans: Lower avoidable utilization, better quality measure performance and member retention. They expect claims-based evidence and a credible comparison group.
• Employers: Lower health spending, fewer missed work days and a benefit employees actually use. They look at enrollment and engagement first, then cost.
• Life sciences companies: Patient recruitment, adherence and real-world data. They need data quality and consent that hold up to regulatory and ethics review.

A single product can serve more than one buyer, but the first contract usually comes from one. Pick the buyer whose benefit your product moves most directly, and design the first release to show it.

Why integration decides most of the value

A digital health tool delivers value only when its data reaches the people who act on it. Clinical data is already digital almost everywhere: ASTP/ONC reports that, as of 2024, 91% of office-based physicians and over 99% of non-federal acute care hospitals had adopted a certified EHR.

That changes the founder's task. The question is not whether the clinic is digital but whether your product fits into the record it already uses. A tool that sends a PDF or asks clinicians to open a separate portal competes with everything else on their screen and usually loses.

Integration works in both directions. Reading from the EHR, through FHIR APIs or HL7 v2 feeds, lets the product start with the patient's problems, medications and recent results instead of asking for them again. Writing back, as results, notes or tasks, puts the product's output where the care team works.

Patients can also bring data with them. CMS's Interoperability and Patient Access final rule (CMS-9115-F, 2020) requires many payers regulated by CMS, including Medicare Advantage organizations, Medicaid and CHIP programs and qualified health plan issuers on the federal exchanges, to offer a Patient Access API that lets members share their claims and clinical data with apps they choose.

For a consumer product, that is a way to fill the record without manual entry. It does require patient authorization flows, payer-by-payer connection work and a clear explanation of what the app does with the data.

How do digital health products get paid for?

A benefit only becomes a business when a payer for it exists. The common routes are fee-for-service billing by a provider, value-based contracts, employer or health plan contracts, and direct patient payment.

Fee-for-service codes set what a provider customer can bill for the work your product supports. In remote monitoring, the CY 2026 Medicare Physician Fee Schedule final rule (CMS-1832-F) added CPT 99445 for 2 to 15 days of device data in a 30-day period and CPT 99470 for the first 10 minutes of treatment management, alongside the existing 16 to 30 day and 20 minute codes.

Codes like these widen the set of patients a provider can enroll profitably, but they also define the product. The software has to count transmission days, log management time by clinician and support the documentation the provider needs for each claim.

Under value-based contracts, the provider or plan is paid for outcomes and total cost, so the benefit has to show up in their quality and utilization reports. Employer and plan contracts often pay per enrolled member, which shifts the founder's focus to enrollment and sustained engagement.

Direct patient payment works for some convenience and wellness products, but it puts the product in competition with every other app on the phone. Pairing it with a sponsored route reduces that risk.

What evidence does a buyer expect?

Buyers expect evidence in stages, and each stage answers a different question. Skipping straight to outcome claims without the earlier stages tends to fail a buyer's review.

• 1. Usability: Can the target patients and clinicians use it? Test with real users of different ages, languages, abilities and connection quality, and fix what they struggle with.
• 2. Engagement: Do people keep using it after the first week? Measure active use against what the care model needs, not downloads or sign-ups.
• 3. Process measures: Does it change what the care team does? Examples are time from an abnormal reading to contact, follow-up visits completed, or staff minutes per patient.
• 4. Clinical outcomes: Does the patient's condition improve? This needs a defined population, a comparison group and enough time for the outcome to move.
• 5. Cost and utilization: Does it change spending or use of services? This usually needs claims data and the buyer's analytics team, so agree the method before the pilot starts.

Agree the measures, data sources and success threshold with the buyer in writing before the pilot. A pilot that ends with each side using different numbers rarely converts to a contract.

Benefits that fail to show up

When a promised benefit does not appear, the cause is usually in the workflow or the data, not the core idea. The failure points below are worth designing against from the start.

• Nobody owns the data: The product produces alerts or reports, but no staffed role reviews them. Fix: agree who acts on each output before launch.
• Engagement drops off: Patients stop using the app after the first weeks. Fix: tie the app to a care team response so using it gets a visible result.
• Outside the record: Output sits in a vendor portal. Fix: write results, notes or tasks into the EHR.
• Wrong population: The pilot enrolls patients who would have done well anyway. Fix: define eligibility with the clinical lead and compare against similar patients.
• Unmeasured baseline: Nobody captured the before numbers. Fix: pull baseline data before go-live.
• Access gaps: Patients with low connectivity, older devices or limited English never enroll. Fix: support audio, SMS, larger text and translated content from the first release.
• Claims that outrun the evidence: Marketing promises outcomes a pilot cannot show yet, and some diagnostic or treatment claims can make a product an FDA-regulated device. Fix: keep claims at the stage the evidence supports and review intended use with regulatory counsel.

How should a startup measure benefit from the first release?

Build measurement into the product rather than bolting it on before a renewal. The data a buyer will ask for in month twelve has to be captured from day one.

Log product events with patient-level identifiers that can later be linked, under the right agreements, to the buyer's clinical or claims data. Keep event names stable, because renaming them breaks every trend line.

Record care team actions, not just patient actions. A process benefit such as faster follow-up can only be shown if the product records when a clinician saw and acted on an alert.

Build the buyer's report early. A simple monthly report with the agreed measures, shared from the first month, surfaces data problems while there is still time to fix them.

Plan for privacy from the start. Identifiable health data needs a clear legal basis, whether HIPAA through a business associate agreement with a covered entity customer or the FTC rules that apply to consumer health apps outside HIPAA, and analytics should use the minimum data each question needs.

How Agnotic can help

Proving a digital health benefit takes engineering in places founders often leave for later: EHR integration, event logging, care team workflows and buyer reporting. Agnotic Technologies builds those pieces for digital health companies alongside the patient and clinician experience, so the first release can already produce the evidence a buyer asks for.

Agnotic works as your development team, scoping the first release around one buyer and one measurable benefit, then extending the product as contracts and evidence grow.

Sources

• ASTP/ONC: National trends in hospital and physician adoption of electronic health records
• CMS: Interoperability and Patient Access final rule (CMS-9115-F)
• CMS: CY 2026 Medicare Physician Fee Schedule final rule (CMS-1832-F) fact sheet